ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
4
views
0
references
Top references
cited by
2
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,968
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Heritage: a phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus Herceptin
Author(s):
HS Rugo
,
A Barve
,
CF Waller
,
Hope S Rugo
,
Abhijit Barve
,
Cornelius Waller
,
Miguel Hernandez-Bronchud
,
Jay Herson
,
Jinyu Yuan
,
Alexey Manikhas
,
Igor Bondarenko
,
Guzel Mukhametshina
,
Gia Nemsadze
,
Joseph D. Parra
,
Maria Tiambeng
,
Kakhaber Baramidze
,
Charuwan Akewanlop
,
Ihor Vynnychenko
,
Virote Sriuranpong
,
Gopichand Manillapalli
,
Sirshendu Ray
,
Eduardo P. Yanez Ruiz
,
Eduardo J. Pennella
Publication date:
2016
Journal:
J Clin Oncol
Read this article at
ScienceOpen
Publisher
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Karger: Oncology
Author and article information
Journal
DOI::
10.1200/JCO.2016.34.15_suppl.LBA503
ScienceOpen disciplines:
Oncology & Radiotherapy
,
Medicine
Data availability:
ScienceOpen disciplines:
Oncology & Radiotherapy
,
Medicine
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,968
A bioequivalence study of proposed bevacizumab biosimilar, MYL-1402O (A) vs EU-Avastin (B) and US-Avastin (C).
Authors:
Mark A. Socinski
,
Matthew T. Hummel
,
Tjerk Bosje
…
Characterization and similarity assessment of a pegfilgrastim biosimilar MYL-1401H.
Authors:
Praveen Sankaran
,
Dinesh Palanivelu
,
Reshmi Nair
…
Establishment and characterization of a novel imatinib-sensitive chronic myeloid leukemia cell line MYL, and an imatinib-resistant subline MYL-R showing overexpression of Lyn.
Authors:
Takuo Ito
,
A Kimura
,
Hideo Tanaka
See all similar
Cited by
2
The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars
Authors:
Liese Barbier
,
Paul Declerck
,
Steven Simoens
…
Biosimilars for breast cancer: a review of HER2-targeted antibodies in the United States
Authors:
Emily Miller
,
Lee S Schwartzberg
See all cited by